Arcutis and Bloomin’ Brands Surge in After-hours Trading on Positive News
Arcutis Biotherapeutics receives a Buy rating upgrade from Mizuho Securities, pushing stock up 6% in after-hours trading.
- Latest
- Trending
Arcutis Biotherapeutics receives a Buy rating upgrade from Mizuho Securities, pushing stock up 6% in after-hours trading.
Airlines continue to face challenges in implementing AI solutions for improved operations, especially in targeted upselling and revenue optimization. Simplification ...
Mercedes-Benz has had a memorable history at Le Mans, from surprising victories to tragic crashes. While they have been absent ...
Eli Lilly strengthens its presence in cancer treatment with the completion of its $1.4 billion acquisition of Point Biopharma, expanding ...
Enhancing your smartwatch experience with Notify for Smartwatches: the app that revolutionizes notifications, providing customizability and reliability. Stay connected and ...
Tesla solidifies its dominance in Norway's EV market, capturing 20% market share despite opposition from labor unions, while EVs make ...
The limitations of using Steamboat Willie's version of Mickey in NFTs: A lawyer warns about copyright restrictions and the need ...
Dogecoin whale movements and price predictions, MATIC's growing enthusiasm, and the emergence of Rebel Satoshi as an alternative option. Get ...
Deutsche Bank downgraded Estee Lauder on near-term risk, while Goldman Sachs initiated Rollins as a buy citing organic revenue growth. ...
Bitcoin developer Jimmy Song voices doubts about the Ordinals protocol, comparing it to an altcoin scam. The debate highlights challenges ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.